John J. Sperzel III

Insider Reports History

Location
Brunswick, ME
Signature
/s/ John Sprague, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Sperzel III:

Company Role Class Num Shares Value Price $ Report Date Ownership
T2 Biosystems, Inc. Chairman, President & CEO, Director Restricted Stock Units 490,000 $77,175 $0.1575 04 Nov 2024 Direct
T2 Biosystems, Inc. Chairman, President & CEO, Director Common Stock 400 $63 $0.1575 24 Feb 2024 Direct

Insider Reports Filed by John J. Sperzel III

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TTOO T2 Biosystems, Inc. 04 Nov 2024 2 $0 4 Chairman, President & CEO, Director 02 Jan 2025, 18:13
TTOO T2 Biosystems, Inc. 24 Feb 2024 2 $0 4 Officer, Director 27 Feb 2024, 16:31
TTOO T2 Biosystems, Inc. 20 Feb 2024 2 $0 4 Chairman, President and Chief Executive Officer, Director 20 Feb 2024, 16:00
TTOO T2 Biosystems, Inc. 20 Feb 2023 6 -$6,179 4 Chairman and CEO, Director 09 Mar 2023, 15:00
TTOO T2 Biosystems, Inc. 07 Apr 2022 1 +$15,000 4 Chairman, CEO, and President, Director 11 Apr 2022, 10:07
TTOO T2 Biosystems, Inc. 24 Feb 2022 3 -$63,532 4 Chairman, Chief Executive Officer and President, Director 28 Feb 2022, 15:00
TTOO T2 Biosystems, Inc. 20 Feb 2022 1 $0 4 Chairman, President and Chief Executive Officer, Director 23 Feb 2022, 17:29